The number of product liability lawsuits over Sanofi-Aventis’s Taxotere causing permanent hair loss in women prescribed the medication for breast cancer reached about 7,500 cases in mid-December 2017, versus 28 cases in October 2016, according to court documents filed in late January. The Taxotere product liability lawsuits each raise similar... Read more »

A court filing in mid-March indicates that over 850 women have brought lawsuits related to Taxotere in a federal multidistrict litigation (MDL). The MDL was specifically set up for claims related to the breast cancer drug, all alleging that Taxotere’s manufacturer Sanofi-Aventis failed to warn patients and healthcare professionals about... Read more »

Earlier in October, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a consolidation order for Taxotere lawsuits filed in federal courts around the country. The claims will now proceed in a multidistrict litigation (MDL) against defendant Sanofi-Aventis. The ruling affects at least 33 cases that had been pending in 16 different U.S.... Read more »

Chemotherapy-related hair loss is common, with about 65% of chemo patients losing their hair. However, hair loss is a harrowing event; according to studies, nearly half of female chemo patients consider it to be the most traumatic part of chemo. The profound impact of hair loss is known to strike... Read more »